Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Organon National Medicaid Settlement

Merck’s Organon subsidiary (Schering-Plough acquired Organon in 2007; Schering-Plough merged with Merck in 2009) agreed to pay $31 million to several states and the federal government for allegedly failing to include discounts and rebates in its pricing, as required by the federal Medicaid Drug Rebate Program. Organon also allegedly offered kickbacks to nursing home pharmacies to encourage use of the Remeron antidepressant and allegedly promoted the medicine for uses not approved by the Food and Drug Administration. Merck did not admit any wrongdoing; the allegations occurred between 1999 and 2005—before Merck acquired Organon.

Misconduct Type
Ethics
Enforcement Agency
Multiple Agencies
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Settlement Announcement
10/15/2014
Contractors Involved Penalty
Total
Merck & Co., Inc. $31,000,000
Further Information Released
New York AG Press Release 10/15/2014
Settlement Agreement 8/7/2014
Complaint 9/13/2007

Federal Contractor Misconduct Database